KR20050072341A - Streptomyces roseoflavus ls-a24 strain effective against plant pathogenic fungi and fungicides produced from it - Google Patents
Streptomyces roseoflavus ls-a24 strain effective against plant pathogenic fungi and fungicides produced from it Download PDFInfo
- Publication number
- KR20050072341A KR20050072341A KR1020040000735A KR20040000735A KR20050072341A KR 20050072341 A KR20050072341 A KR 20050072341A KR 1020040000735 A KR1020040000735 A KR 1020040000735A KR 20040000735 A KR20040000735 A KR 20040000735A KR 20050072341 A KR20050072341 A KR 20050072341A
- Authority
- KR
- South Korea
- Prior art keywords
- strain
- streptomyces
- fungicides
- plant diseases
- rhizoctonia solani
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000000417 fungicide Substances 0.000 title claims abstract description 26
- 241000187438 Streptomyces fradiae Species 0.000 title claims abstract description 24
- 244000000004 fungal plant pathogen Species 0.000 title description 2
- HKSZLNNOFSGOKW-UHFFFAOYSA-N ent-staurosporine Natural products C12=C3N4C5=CC=CC=C5C3=C3CNC(=O)C3=C2C2=CC=CC=C2N1C1CC(NC)C(OC)C4(C)O1 HKSZLNNOFSGOKW-UHFFFAOYSA-N 0.000 claims abstract description 32
- HKSZLNNOFSGOKW-FYTWVXJKSA-N staurosporine Chemical compound C12=C3N4C5=CC=CC=C5C3=C3CNC(=O)C3=C2C2=CC=CC=C2N1[C@H]1C[C@@H](NC)[C@@H](OC)[C@]4(C)O1 HKSZLNNOFSGOKW-FYTWVXJKSA-N 0.000 claims abstract description 32
- 201000010099 disease Diseases 0.000 claims abstract description 31
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 31
- 230000000845 anti-microbial effect Effects 0.000 claims abstract description 30
- 241000813090 Rhizoctonia solani Species 0.000 claims abstract description 14
- 239000000126 substance Substances 0.000 claims abstract description 11
- CGPUWJWCVCFERF-UHFFFAOYSA-N staurosporine Natural products C12=C3N4C5=CC=CC=C5C3=C3CNC(=O)C3=C2C2=CC=CC=C2N1C1CC(NC)C(OC)C4(OC)O1 CGPUWJWCVCFERF-UHFFFAOYSA-N 0.000 claims abstract description 10
- 241000233616 Phytophthora capsici Species 0.000 claims abstract description 9
- 241000395107 Cladosporium cucumerinum Species 0.000 claims abstract description 8
- 241000123650 Botrytis cinerea Species 0.000 claims abstract description 6
- 241001270527 Phyllosticta citrullina Species 0.000 claims abstract description 6
- 241000611205 Fusarium oxysporum f. sp. lycopersici Species 0.000 claims abstract description 5
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims abstract description 5
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 claims abstract description 5
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 claims abstract description 5
- 239000001751 lycopene Substances 0.000 claims abstract description 5
- 229960004999 lycopene Drugs 0.000 claims abstract description 5
- 235000012661 lycopene Nutrition 0.000 claims abstract description 5
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 claims abstract description 5
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 54
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 9
- 230000000843 anti-fungal effect Effects 0.000 claims description 9
- 230000003032 phytopathogenic effect Effects 0.000 claims description 9
- 239000001888 Peptone Substances 0.000 claims description 8
- 108010080698 Peptones Proteins 0.000 claims description 8
- 235000019319 peptone Nutrition 0.000 claims description 8
- 239000003480 eluent Substances 0.000 claims description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 6
- 239000011347 resin Substances 0.000 claims description 6
- 229920005989 resin Polymers 0.000 claims description 6
- 239000004599 antimicrobial Substances 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 5
- 238000003818 flash chromatography Methods 0.000 claims description 5
- 230000000813 microbial effect Effects 0.000 claims description 5
- 238000004809 thin layer chromatography Methods 0.000 claims description 5
- XELZGAJCZANUQH-UHFFFAOYSA-N methyl 1-acetylthieno[3,2-c]pyrazole-5-carboxylate Chemical compound CC(=O)N1N=CC2=C1C=C(C(=O)OC)S2 XELZGAJCZANUQH-UHFFFAOYSA-N 0.000 claims description 3
- 239000012046 mixed solvent Substances 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 238000004007 reversed phase HPLC Methods 0.000 claims description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 2
- 238000004440 column chromatography Methods 0.000 claims description 2
- 239000000741 silica gel Substances 0.000 claims description 2
- 229910002027 silica gel Inorganic materials 0.000 claims description 2
- 239000002689 soil Substances 0.000 abstract description 17
- 230000000855 fungicidal effect Effects 0.000 abstract description 15
- 230000003115 biocidal effect Effects 0.000 abstract description 8
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 7
- 239000001963 growth medium Substances 0.000 abstract description 3
- 241000187747 Streptomyces Species 0.000 description 22
- 241000196324 Embryophyta Species 0.000 description 20
- 241000186361 Actinobacteria <class> Species 0.000 description 14
- 239000003242 anti bacterial agent Substances 0.000 description 14
- 230000000694 effects Effects 0.000 description 14
- 240000004160 Capsicum annuum Species 0.000 description 13
- 241000722363 Piper Species 0.000 description 13
- 229940088710 antibiotic agent Drugs 0.000 description 13
- 239000002609 medium Substances 0.000 description 12
- 241000894006 Bacteria Species 0.000 description 11
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 11
- 241000233866 Fungi Species 0.000 description 11
- 229920001817 Agar Polymers 0.000 description 10
- 239000008272 agar Substances 0.000 description 10
- 230000003042 antagnostic effect Effects 0.000 description 10
- 235000002566 Capsicum Nutrition 0.000 description 9
- 235000007862 Capsicum baccatum Nutrition 0.000 description 9
- 239000006002 Pepper Substances 0.000 description 9
- 235000016761 Piper aduncum Nutrition 0.000 description 9
- 235000017804 Piper guineense Nutrition 0.000 description 9
- 235000008184 Piper nigrum Nutrition 0.000 description 9
- 239000001728 capsicum frutescens Substances 0.000 description 9
- 229920002472 Starch Polymers 0.000 description 8
- 239000008107 starch Substances 0.000 description 8
- 235000019698 starch Nutrition 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 108020004465 16S ribosomal RNA Proteins 0.000 description 6
- 244000005700 microbiome Species 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 229930000044 secondary metabolite Natural products 0.000 description 5
- 240000007594 Oryza sativa Species 0.000 description 4
- 235000007164 Oryza sativa Nutrition 0.000 description 4
- 241001620634 Roger Species 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- YPHMISFOHDHNIV-FSZOTQKASA-N cycloheximide Chemical compound C1[C@@H](C)C[C@H](C)C(=O)[C@@H]1[C@H](O)CC1CC(=O)NC(=O)C1 YPHMISFOHDHNIV-FSZOTQKASA-N 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 4
- 239000012678 infectious agent Substances 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 235000009566 rice Nutrition 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- 241000412366 Alternaria mali Species 0.000 description 3
- 241001465180 Botrytis Species 0.000 description 3
- 240000008067 Cucumis sativus Species 0.000 description 3
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 3
- 229920001353 Dextrin Polymers 0.000 description 3
- 239000004375 Dextrin Substances 0.000 description 3
- 239000005807 Metalaxyl Substances 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 244000061456 Solanum tuberosum Species 0.000 description 3
- 235000002595 Solanum tuberosum Nutrition 0.000 description 3
- 241000607479 Yersinia pestis Species 0.000 description 3
- 229940121375 antifungal agent Drugs 0.000 description 3
- 239000005018 casein Substances 0.000 description 3
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 3
- 235000021240 caseins Nutrition 0.000 description 3
- 235000019425 dextrin Nutrition 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 230000002538 fungal effect Effects 0.000 description 3
- 231100000053 low toxicity Toxicity 0.000 description 3
- ZQEIXNIJLIKNTD-UHFFFAOYSA-N methyl N-(2,6-dimethylphenyl)-N-(methoxyacetyl)alaninate Chemical compound COCC(=O)N(C(C)C(=O)OC)C1=C(C)C=CC=C1C ZQEIXNIJLIKNTD-UHFFFAOYSA-N 0.000 description 3
- 239000000575 pesticide Substances 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- GMKMEZVLHJARHF-UHFFFAOYSA-N (2R,6R)-form-2.6-Diaminoheptanedioic acid Natural products OC(=O)C(N)CCCC(N)C(O)=O GMKMEZVLHJARHF-UHFFFAOYSA-N 0.000 description 2
- CXNPLSGKWMLZPZ-GIFSMMMISA-N (2r,3r,6s)-3-[[(3s)-3-amino-5-[carbamimidoyl(methyl)amino]pentanoyl]amino]-6-(4-amino-2-oxopyrimidin-1-yl)-3,6-dihydro-2h-pyran-2-carboxylic acid Chemical compound O1[C@@H](C(O)=O)[C@H](NC(=O)C[C@@H](N)CCN(C)C(N)=N)C=C[C@H]1N1C(=O)N=C(N)C=C1 CXNPLSGKWMLZPZ-GIFSMMMISA-N 0.000 description 2
- QKJJCZYFXJCKRX-HZHKWBLPSA-N 2-[(2s,3s,6r)-6-[4-amino-5-(hydroxymethyl)-2-oxopyrimidin-1-yl]-3-[[(2s)-2-amino-3-hydroxypropanoyl]amino]-3,6-dihydro-2h-pyran-2-yl]-5-(diaminomethylideneamino)-2,4-dihydroxypentanoic acid Chemical compound O1[C@H](C(O)(CC(O)CN=C(N)N)C(O)=O)[C@@H](NC(=O)[C@H](CO)N)C=C[C@@H]1N1C(=O)N=C(N)C(CO)=C1 QKJJCZYFXJCKRX-HZHKWBLPSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 239000005730 Azoxystrobin Substances 0.000 description 2
- 235000002283 Capsicum annuum var aviculare Nutrition 0.000 description 2
- 235000013303 Capsicum annuum var. frutescens Nutrition 0.000 description 2
- 235000002284 Capsicum baccatum var baccatum Nutrition 0.000 description 2
- 235000002568 Capsicum frutescens Nutrition 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 102000016942 Elastin Human genes 0.000 description 2
- 108010014258 Elastin Proteins 0.000 description 2
- 102000002068 Glycopeptides Human genes 0.000 description 2
- 108010015899 Glycopeptides Proteins 0.000 description 2
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- 241001344131 Magnaporthe grisea Species 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 206010035148 Plague Diseases 0.000 description 2
- JPFWJDMDPLEUBD-UHFFFAOYSA-N Polyoxin D Natural products OC1C(O)C(C(NC(=O)C(C(O)C(O)COC(N)=O)N)C(O)=O)OC1N1C(=O)NC(=O)C(C(O)=O)=C1 JPFWJDMDPLEUBD-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 238000012300 Sequence Analysis Methods 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 229940126575 aminoglycoside Drugs 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 229960000271 arbutin Drugs 0.000 description 2
- WFDXOXNFNRHQEC-GHRIWEEISA-N azoxystrobin Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1OC1=CC(OC=2C(=CC=CC=2)C#N)=NC=N1 WFDXOXNFNRHQEC-GHRIWEEISA-N 0.000 description 2
- 239000003899 bactericide agent Substances 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 238000010876 biochemical test Methods 0.000 description 2
- CXNPLSGKWMLZPZ-UHFFFAOYSA-N blasticidin-S Natural products O1C(C(O)=O)C(NC(=O)CC(N)CCN(C)C(N)=N)C=CC1N1C(=O)N=C(N)C=C1 CXNPLSGKWMLZPZ-UHFFFAOYSA-N 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 231100000676 disease causative agent Toxicity 0.000 description 2
- 229920002549 elastin Polymers 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000002143 fast-atom bombardment mass spectrum Methods 0.000 description 2
- 239000004021 humic acid Substances 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 229960000367 inositol Drugs 0.000 description 2
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 2
- PVTHJAPFENJVNC-MHRBZPPQSA-N kasugamycin Chemical compound N[C@H]1C[C@H](NC(=N)C(O)=O)[C@@H](C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H]1O PVTHJAPFENJVNC-MHRBZPPQSA-N 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- GMKMEZVLHJARHF-SYDPRGILSA-N meso-2,6-diaminopimelic acid Chemical compound [O-]C(=O)[C@@H]([NH3+])CCC[C@@H]([NH3+])C([O-])=O GMKMEZVLHJARHF-SYDPRGILSA-N 0.000 description 2
- KCIRYJNISRMYFI-UHFFFAOYSA-N mildiomycin Natural products NC(CO)C(=O)NC1C=CC(OC1C(O)(CC(O)CNC(=N)N)C(=O)O)N2CN=C(N)C(=C2)CO KCIRYJNISRMYFI-UHFFFAOYSA-N 0.000 description 2
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- JPFWJDMDPLEUBD-ITJAGOAWSA-N polyoxorim Polymers O[C@@H]1[C@H](O)[C@@H]([C@H](NC(=O)[C@H]([C@H](O)[C@@H](O)COC(N)=O)N)C(O)=O)O[C@H]1N1C(=O)NC(=O)C(C(O)=O)=C1 JPFWJDMDPLEUBD-ITJAGOAWSA-N 0.000 description 2
- QJBZDBLBQWFTPZ-UHFFFAOYSA-N pyrrolnitrin Chemical compound [O-][N+](=O)C1=C(Cl)C=CC=C1C1=CNC=C1Cl QJBZDBLBQWFTPZ-UHFFFAOYSA-N 0.000 description 2
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000008223 sterile water Substances 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000006273 synthetic pesticide Substances 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 239000007164 v-8 juice agar Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- 150000003952 β-lactams Chemical class 0.000 description 2
- 101710175516 14 kDa zinc-binding protein Proteins 0.000 description 1
- PWKSKIMOESPYIA-UHFFFAOYSA-N 2-acetamido-3-sulfanylpropanoic acid Chemical compound CC(=O)NC(CS)C(O)=O PWKSKIMOESPYIA-UHFFFAOYSA-N 0.000 description 1
- LQAQMOIBXDELJX-UHFFFAOYSA-N 2-methoxyprop-2-enoic acid Chemical class COC(=C)C(O)=O LQAQMOIBXDELJX-UHFFFAOYSA-N 0.000 description 1
- VFUQDUGKYYDRMT-UHFFFAOYSA-N 3-methoxyprop-2-enoic acid Chemical compound COC=CC(O)=O VFUQDUGKYYDRMT-UHFFFAOYSA-N 0.000 description 1
- QJZYHAIUNVAGQP-UHFFFAOYSA-N 3-nitrobicyclo[2.2.1]hept-5-ene-2,3-dicarboxylic acid Chemical compound C1C2C=CC1C(C(=O)O)C2(C(O)=O)[N+]([O-])=O QJZYHAIUNVAGQP-UHFFFAOYSA-N 0.000 description 1
- PLXMOAALOJOTIY-FPTXNFDTSA-N Aesculin Natural products OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1Oc2cc3C=CC(=O)Oc3cc2O PLXMOAALOJOTIY-FPTXNFDTSA-N 0.000 description 1
- 235000005254 Allium ampeloprasum Nutrition 0.000 description 1
- 240000006108 Allium ampeloprasum Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- WNBCMONIPIJTSB-BGNCJLHMSA-N Cichoriin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)c1c(O)cc2c(OC(=O)C=C2)c1 WNBCMONIPIJTSB-BGNCJLHMSA-N 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 241000222290 Cladosporium Species 0.000 description 1
- 241000222199 Colletotrichum Species 0.000 description 1
- 241000032203 Conus aureus Species 0.000 description 1
- 102000016736 Cyclin Human genes 0.000 description 1
- 108050006400 Cyclin Proteins 0.000 description 1
- 241000723247 Cylindrocarpon Species 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- QWIZNVHXZXRPDR-UHFFFAOYSA-N D-melezitose Natural products O1C(CO)C(O)C(O)C(O)C1OC1C(O)C(CO)OC1(CO)OC1OC(CO)C(O)C(O)C1O QWIZNVHXZXRPDR-UHFFFAOYSA-N 0.000 description 1
- 241000221785 Erysiphales Species 0.000 description 1
- 239000005781 Fludioxonil Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000223195 Fusarium graminearum Species 0.000 description 1
- 241000223221 Fusarium oxysporum Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241000282414 Homo sapiens Species 0.000 description 1
- -1 Humic acid vitamin Chemical class 0.000 description 1
- 239000005800 Kresoxim-methyl Substances 0.000 description 1
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 241000315044 Passalora arachidicola Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000233614 Phytophthora Species 0.000 description 1
- 241001281803 Plasmopara viticola Species 0.000 description 1
- 101100505672 Podospora anserina grisea gene Proteins 0.000 description 1
- 229930182764 Polyoxin Natural products 0.000 description 1
- 229940123924 Protein kinase C inhibitor Drugs 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 241000295644 Staphylococcaceae Species 0.000 description 1
- 241000187180 Streptomyces sp. Species 0.000 description 1
- 229930182692 Strobilurin Natural products 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- 229930195482 Validamycin Natural products 0.000 description 1
- 241000228452 Venturia inaequalis Species 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 229940045799 anthracyclines and related substance Drugs 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000003967 crop rotation Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001493 electron microscopy Methods 0.000 description 1
- AWRMZKLXZLNBBK-UHFFFAOYSA-N esculin Natural products OC1OC(COc2cc3C=CC(=O)Oc3cc2O)C(O)C(O)C1O AWRMZKLXZLNBBK-UHFFFAOYSA-N 0.000 description 1
- XHCADAYNFIFUHF-TVKJYDDYSA-N esculin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC2=C1OC(=O)C=C2 XHCADAYNFIFUHF-TVKJYDDYSA-N 0.000 description 1
- 229940093496 esculin Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 210000003495 flagella Anatomy 0.000 description 1
- MUJOIMFVNIBMKC-UHFFFAOYSA-N fludioxonil Chemical compound C=12OC(F)(F)OC2=CC=CC=1C1=CNC=C1C#N MUJOIMFVNIBMKC-UHFFFAOYSA-N 0.000 description 1
- 244000053095 fungal pathogen Species 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 229960002885 histidine Drugs 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229940043355 kinase inhibitor Drugs 0.000 description 1
- ZOTBXTZVPHCKPN-HTXNQAPBSA-N kresoxim-methyl Chemical compound CO\N=C(\C(=O)OC)C1=CC=CC=C1COC1=CC=CC=C1C ZOTBXTZVPHCKPN-HTXNQAPBSA-N 0.000 description 1
- 150000002611 lead compounds Chemical class 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000003120 macrolide antibiotic agent Substances 0.000 description 1
- 229940041033 macrolides Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- QWIZNVHXZXRPDR-WSCXOGSTSA-N melezitose Chemical compound O([C@@]1(O[C@@H]([C@H]([C@@H]1O[C@@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O)CO)CO)[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O QWIZNVHXZXRPDR-WSCXOGSTSA-N 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 239000002032 methanolic fraction Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 208000013435 necrotic lesion Diseases 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 229940014662 pantothenate Drugs 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229960005190 phenylalanine Drugs 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 239000003757 phosphotransferase inhibitor Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000005080 plant death Effects 0.000 description 1
- 150000004291 polyenes Chemical class 0.000 description 1
- YEBIHIICWDDQOL-YBHNRIQQSA-N polyoxin Polymers O[C@@H]1[C@H](O)[C@@H](C(C=O)N)O[C@H]1N1C(=O)NC(=O)C(C(O)=O)=C1 YEBIHIICWDDQOL-YBHNRIQQSA-N 0.000 description 1
- 239000001965 potato dextrose agar Substances 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000003881 protein kinase C inhibitor Substances 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 229960002132 pyrrolnitrin Drugs 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 238000001878 scanning electron micrograph Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- UQDJGEHQDNVPGU-UHFFFAOYSA-N serine phosphoethanolamine Chemical compound [NH3+]CCOP([O-])(=O)OCC([NH3+])C([O-])=O UQDJGEHQDNVPGU-UHFFFAOYSA-N 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 1
- 239000011747 thiamine hydrochloride Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 241001446247 uncultured actinomycete Species 0.000 description 1
- JARYYMUOCXVXNK-IMTORBKUSA-N validamycin Chemical compound N([C@H]1C[C@@H]([C@H]([C@H](O)[C@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)CO)[C@H]1C=C(CO)[C@H](O)[C@H](O)[C@H]1O JARYYMUOCXVXNK-IMTORBKUSA-N 0.000 description 1
- 229960004295 valine Drugs 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229940075420 xanthine Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
- A01N63/20—Bacteria; Substances produced thereby or obtained therefrom
- A01N63/28—Streptomyces
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Dentistry (AREA)
- Environmental Sciences (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
본 발명은 토양으로부터 분리한 신규의 스트렙토마이세스 로제오플라브스 LS-A24(Streptomyces roseoflavus LS-A24) 균주와 이 균주 배양액으로부터 분리, 추출되는 항균물질인 스타우로스포린(staurosporine) 및 이 항생물질을 이용하는 식물병 방제용 살균제 등에 관한 것이다.The present invention relates to a novel Streptomyces roseoflavus LS-A24 strain isolated from soil , and staurosporine, which is an antibacterial substance extracted and extracted from the strain culture medium, and this antibiotic. It relates to a fungicide for plant disease control to be used.
본 발명의 신규 균주 및 이로부터 분리되는 항균물질은 식물병원진균인 보트리티스 시네리아(Botrytis cinerea), 콜렉토트리큠 오비큘라리에(Collectotrichum orbiculare), 클라도스포리움 쿠쿠메리눔(Cladosporium cucumerinum), 디디멜라 브리오니에(Didymella bryoniae), 푸자리움 옥시스포름 f.sp. 라이코퍼시시(Fusarium oxysporum f.sp. lycopersici), 라이족토니아 솔라니 (Rhizoctonia solani) 및 파이토프소라 캡시사이(Phytophthora capsici) 등에 대한 항균효과를 가진다.The novel strains of the present invention and the antimicrobial substances isolated therefrom are Botrytis cinerea , Botantis cinerea , Collectotrichum orbiculare , Cladosporium cucumerinum ), Didymella bryoniae , Fujium oxysporum f.sp. Lycopene has an anti-bacterial effects, etc. When Percy (Fusarium oxysporum f.sp. Lycopersici), Rhizoctonia solani (Rhizoctonia solani), and between the pie Saratov seashell kaepsi (Phytophthora capsici).
Description
본 발명은 신규의 항진균성 활성을 가지는 스트렙토마이세스 로제오플라브스(Streptomyces roseoflavus) 균주, 및 그로부터 생산되는 항생물질을 이용하는 살균제에 관한 것으로서, 구체적으로는 고추역병균, 잿빛곰팡이병균 등의 식물병원 진균에 대해 항균효과를 나타내는 항생물질인 스타우로스포린(staurosporine)을 생성, 분비함으로써 신규의 항진균성 활성을 가지는 스트렙토마이세스 로제오플라브스 LS-A24(Streptomyces roseoflavus LS-A24)균주, 및 그로부터 생산되는 항생물질 스타우로스포린을 이용하는 살균제에 관한 것에 관한 것이다.The present invention relates to a Streptomyces roseoflavus strain having a novel antifungal activity, and to a fungicide using antibiotics produced therefrom, and specifically, to a plant hospital such as red pepper bacterium and gray mold fungi. Streptomyces roseoflavus LS-A24 strain having a novel antifungal activity by producing and secreting an antibiotic, staurosporine, which has an antimicrobial effect against fungi, and produced therefrom It relates to a fungicide using the antibiotic staurosporin.
일반적으로 고추역병과 잿빛곰팡이병은 우리나라에서 경제적으로 매우 중요한 식물병으로써, 이에 대해 구체적으로 설명하면 다음과 같다.Generally, pepper blight and gray mold are economically important plant diseases in Korea.
고추역병은 유묘기부터 전 생육기에 걸쳐 주로 뿌리와 줄기 부위에 발생되지만, 병원균이 빗물에 튀어 올라 잎, 열매, 가지 등의 지상부에도 발생하는 병으로서, 일단 유묘기에 감염되면 그루 전체가 심하게 시들어 죽게 되고, 생육 중기나 후기의 병든 그루는 처음에 시들다가 후에 적황색으로 변해 말라죽게 된다.Cayenne pepper plague occurs mainly in the roots and stems from the seedling stage to the entire growing season.However, pathogens splash into the rainwater and occur on the ground, such as leaves, fruits, and branches. In the middle of growth or in later stages, the diseased tree is wilted at first and later turns yellow to dry.
고추역병을 일으키는 파이토프소라 캡시사이(Phytophthora capsici)는 물을 좋아하는 반수생균으로 물속이나 배양기상에서 유주자낭을 쉽게 형성하고, 여기서 유출된 유주자는 2개의 편모를 가지고 물속을 유영하며 전반된다. 고추역병의 병원균은 병든 식물체의 조직에서 균사나 난포자 상태로 월동한 후 다시 발아하여 1차 전염원이 되는 것으로, 이를 좀더 구체적으로 설명하면 다음과 같다. Phytophthora capsici , a causative agent of cayenne pepper, is a water-loving hemi-aquatic bacterium that easily forms a zygote capsule in water or on an incubator, where the spilled swab swims in water with two flagella. The causative agent of red pepper disease is the primary infectious agent after overwintering in the form of mycelium or follicle in the diseased plant tissues and becoming a primary infectious agent.
고추역병은 육묘상에서부터 전 생육기에 발생되며 시설재배에서는 연중 발생되는 것으로, 토양이 장기간 과습하거나 배수가 불량하고, 침수되면 병발생 환경이 조장된다. 특히, 상기 고추역병은 종자전염도 가능하나, 대부분의 전염원은 토양에서 유입되기 때문에 방제상에 어려움이 있다.Red pepper plague occurs from seedlings to all growing seasons, and in plant cultivation throughout the year, and when the soil is excessively moist or poorly drained and flooded, the disease-producing environment is promoted. In particular, the pepper blight is also possible seed transmission, most infectious agents are difficult to control because it is introduced from the soil.
잿빛곰팡이병은 고추, 오이, 감귤, 부추, 토마토, 감자 등의 원예작물 및 화훼작물의 과실과 줄기 및 가지에 발생하는 병으로서, 풋과실의 꽃이 달린 부위에서부터 회색으로 물러 썩다가 진전되면 과실의 안쪽으로 썩어 올라가고 감염부위에는 후에 잿빛의 곰팡이가 많이 형성되는 병이다.Gray mold is a disease that occurs in the fruits, stems, and branches of horticultural crops such as red pepper, cucumber, citrus, leek, tomatoes, potatoes, and flower crops. It is a disease that causes rotting inwards and a lot of gray mold on the infected area.
병원균은 병든 부위에서 균핵 또는 분생포자의 형태로 월동하여 전염원이 되며, 시설재배시에는 기온이 20도 내외에 습도가 높을 때 많이 발생하고, 노지재배시에는 여름철 장마기 때 주로 발생한다.Pathogens overwinter in the form of fungal nuclei or conidia in the diseased area and become infectious agents. In plant cultivation, many occur when the temperature is high around 20 degrees, and during the rainy season during the summer rainy season.
이와 같은 고추역병 및 잿빛곰팡이병 등은 심할 경우 전체 작물 수확에서 약 20% 이상의 수량을 감소시키는 원인이 되므로, 이의 방제를 위해서 현재 저항성품종의 재배, 윤작 등이 행하여지고 있으나, 지금까지 가장 효율적인 방제법은 살균제를 이용한 화학적 방제인 것으로 알려져 있다. 이러한 화학적 방제의 규모를 살펴보면, 고추역병의 경우만 하더라도, 고추재배토양에 사용되고 있는 살균제의 양이 83,000정보의 포장에 약 1,000 M/T(1993)로서, 이렇게 사용된 유기합성농약에 의한 환경 및 인축에 대한 부작용이 심각한 수준에 이르러 사회문제를 유발하고 있는 실정이다.Such pepper blight and gray mold disease cause severe yield reduction of more than 20% in the whole crop harvest. Therefore, cultivation and crop rotation of resistant varieties are currently being carried out for its control, but so far the most effective Silver is known to be a chemical control using a fungicide. Looking at the scale of such chemical control, even in the case of pepper blight, the amount of fungicide used for red pepper cultivation soil is about 1,000 M / T (1993) in the packaging of 83,000 information. The adverse effects on the human beings have reached a serious level, causing social problems.
이러한 관점에서 고추역병, 잿빛곰팡이병 등의 방제에 사용할 수 있는 저독성이고 환경에 부작용을 일으키지 않는 무공해 살균제의 개발이 절실하게 요청되는 상황이라고 할 수 있다.From this point of view, there is an urgent need to develop a low-toxic, pollution-free fungicide that can be used for the control of pepper blight, gray mold, and the like.
이와 같은 저독성 무공해 살균제로서 미생물로부터 분비되는 이차대사산물을 활용하는 방안이 떠오르고 있는데, 이는 미생물 이차대사산물이 식물병 방제를 위한 살균제로서의 여러 가지 유용한 특성을 가지고 있기 때문으로서, 미생물 유래 항생물질은 자연 환경에서 빠르게 분해되어 토양 잔류 독성에 의한 피해가 적으며, 화학구조와 생물학적 효과가 다양하여 유기합성 농약에 대한 약제 저항성을 가진 병원성 균주의 출현, 토양 내 잔류, 인축에 대한 피해 등을 포함한 부작용을 줄일 수 있는 장점을 가지고 있다.The use of secondary metabolites secreted from microorganisms has emerged as a low-toxic, pollution-free bactericide because microbial secondary metabolites have various useful properties as fungicides for controlling plant diseases. It is rapidly decomposed in the environment, so there is little damage due to soil residual toxicity, and the chemical structure and biological effects are varied, and it has side effects including the emergence of pathogenic strains resistant to organic synthetic pesticides, residues in soil, and damage to livestock. It has the advantage of being reduced.
최근 새로운 농약 개발은, 이러한 미생물 이차대사산물의 장점을 살려, 기존 농약과 같이 약효만을 중시하지 않고, 인축에 독성이 낮고, 병해충 및 잡초에 대한 활성이 높은 반면에, 환경 및 자연 생태계에 안전한 고도의 선택성, 저독성 및 환경안정성이 높은 천연물 유래 선도화합물(lead compound) 개발쪽으로 연구가 집중되고 있다.In recent years, the development of new pesticides, taking advantage of these microbial secondary metabolites, does not focus only on medicinal effects like conventional pesticides, has low toxicity to livestock, high activity against pests and weeds, and is safe for environmental and natural ecosystems. Research is focused on developing lead compounds derived from natural products with high selectivity, low toxicity and environmental stability.
한편, 이와 같은 미생물유래 항균물질은 그 자체로서 사용되기도 하지만, 보다 강력하고 안전한 새로운 살균제의 개발을 위한 선구물질로도 많이 사용되고 있는데, 예를 들어, β-메톡시아크릴레이트 아족시스트로빈(β-methoxyacrylates azoxystrobin)과 크레스옥심-메틸(kresoxim-methyl)은 벤츄리아 이나에쿠알리스(Venturia inaequalis), 세프코스포라 아라키디콜라(Cercospora arachidicola), 플라스모포라 비티콜라(Plasmopara viticola) 그리고 파이토프소라 인페스탕스(Phytophthora infestancs)를 억제하는 스트로빌루린(strobilurin)으로부터 개발되었고 옥수수 푸사리움 그라미네아럼(Fusarium graminearum)과 밀 걸라키아 시발리스(Gerlachia civalis)에 항균 효과가 있는 페니클로닐(feniclonil)과 플루디옥소닐(fludioxonil)은 피롤니트린(pyrrolnitrin)으로부터 개발된 농용 살균제이다.On the other hand, although such microorganism-derived antimicrobials are used as such, they are also widely used as precursors for the development of new and more powerful fungicides. For example, β-methoxyacrylate azoxystrobin (β- The methoxyacrylates azoxystrobin and kresoxim-methyl are Venturia inaequalis , Cercospora arachidicola , Plasmopara viticola , and phytoprosolain . Fenyllonil, which was developed from strobilurin, which inhibits Phytophthora infestancs , and has antimicrobial effects on corn Fusarium graminearum and Gerlachia civalis . Fludioxonil is an agricultural fungicide developed from pyrrolnitrin.
지난 30년 동안 내에 시장에 시판된 미생물 유래 살균제는 blasticidin S, polyoxin, kasugamycin, validamycin, mildiomycin이 있는데, 이중 농용 항생제로서 처음으로 개발된 물질은 blasticidin S로 벼도열병에 대해 뛰어난 방제효과를 나타낸 바 있으며, polyoxin D는 과수, 채소, 화훼의 병원성 진균에 사용하고 있고, polyoxin D는 Rhizoctonia solani가 일으키는 벼잎집무늬마름병 방제를 위해 Zn-salt란 이름으로 판매되고 있으며, kasugamycin은 벼도열병과 세균성 Pseudomonas방제에 이용하고 있고, mildiomycin은 여러 작물의 흰가루병 방제에 사용되고 있다.The microbial fungicides on the market for the past 30 years include blasticidin S, polyoxin, kasugamycin, validamycin and mildiomycin. Among the first agricultural antibiotics, blasticidin S has been shown to have excellent control against rice fever. , polyoxin D is used for pathogenic fungi of fruit trees, vegetables, and flowers, polyoxin D is sold under the name Zn-salt for the control of rice leaf blight caused by Rhizoctonia solani , and kasugamycin is used for the control of rice fever and bacterial Pseudomonas. Mildiomycin is used to control powdery mildew in many crops.
한편, 이미 기존에 알려진 많은 수의 항생물질이 방선균으로부터 분리되었는데, 그중에서도 스트렙토마이세스(Streptomyces) 속의 방선균은 아미노글리코사이드(aminoglycosides), 안쓰라사이클린(anthracyclines), 글리코펩타이드(glycopeptides), 베타락탐(β-lactams), 마크로라이드(macrolides), 핵산계(nucleotides), 펩타이드계(peptides), 폴리엔(polyenes) 등의 다양한 종류의 화학구조를 가진 항생물질을 생성하는 것으로 잘 알려져 있어서 집중적으로 탐색이 시도되고 있는 종이다.On the other hand, were a large number of antibiotics already known in conventional isolated from Streptomyces, among others Streptomyces (Streptomyces) the genus Streptomyces is the aminoglycoside (aminoglycosides), not bitter cyclin (anthracyclines), glycopeptides (glycopeptides), beta-lactams ( It is well known for producing antibiotics with various chemical structures such as β-lactams, macrolides, nucleic acids, peptides, and polyenes. It's a species being tried.
그러나, 이와 같은 활발한 탐색 및 연구에도 불구하고, 스트렙토마이세스(Streptomyces) 속의 방선균 중에서 로제오플라브스(roseoflavus) 종의 방선균은 다양한 생리활성물질을 생성할 가능성이 높음에도 불구하고 아직까지 농용항생제와 관련한 연구는 많이 이루어지지 못하고 있는 상황이다.However, with this active navigation, and even less, Streptomyces (Streptomyces) of Rose O 'Rab's (roseoflavus) from the genus Streptomyces species of Streptomyces is Agricultural up despite the possibility is high to generate a variety of physiologically active substances and yet Antibiotics Research There is not much research on this.
본 발명은 상기와 같은 종래 기술의 문제점 및 요구를 해소하기 위한 것으로, 그 목적은, 고추역병, 잿빛곰팡이병 등의 식물병 방제에 사용될 수 있는 저독성이고 환경에 부작용을 일으키지 않는 친환경적 살균제를 제공하고자 하는 것이다.The present invention is to solve the problems and demands of the prior art as described above, the object is to provide a low-toxic and environmentally friendly disinfectant that can be used in the control of plant diseases such as pepper blight, gray mold, etc. It is.
이를 위한 본 발명은, 토양으로부터 분리한 신규의 스트렙토마이세스 로제오플라브스 LS-A24(Streptomyces roseoflavus LS-A24) 균주와 이 균주 배양액으로부터 분리, 추출되는 항생물질인 스타우로스포린(staurosporine)의 제조방법 및 이 항생물질을 이용하는 식물병 방제용 살균제를 제공하는 것으로 이루어진다.To this end, the present invention, the production of a novel Streptomyces roseoflavus LS-A24 strain isolated from the soil and antibiotics staurosporine, which is isolated and extracted from the strain culture solution It provides a method and a fungicide for controlling plant diseases using the antibiotic.
본 발명자들은 한국의 서해안 지역의 갯벌 토양으로부터 약 1,000여 개의 방선균을 분리하여 한천배지 및 온실조건하에서 역가를 검정한 결과, 고추역병균을 비롯한 식물병에 대해 항균효과가 뛰어난 항균활성물질 스타우로스포린(staurosporine)을 생성하는 방선균 균주 LS-A24를 선발하고 동정하였다.The present inventors separated about 1,000 actinomycetes from the mud flat soil of the west coast of Korea, and assayed the titer under agar medium and greenhouse conditions. Actinomycete strain LS-A24 producing (staurosporine) was selected and identified.
본 발명의 방선균 균주 LS-A24는 생리, 생화학적 특성, 그리고 16S rDNA 서열(sequence) 분석을 통해 스트렙토마이세스 로제오플라브스(Streptomyces roseoflavus)로 동정되었다.Actinomycetes strain LS-A24 of the present invention was identified as Streptomyces roseoflavus through physiological, biochemical properties, and 16S rDNA sequence analysis.
구체적으로, 본 발명자들은 고려대학교 농생물학과에서 1990년부터 토양미생물로부터 항진균성 항생물질을 개발하기 위한 연구를 수행하던 중, 식물병원진균에 대해 뛰어난 항균활성을 보이는 항진균 항생물질을 생성하는 다수의 길항방선균을 발견하게 되었으며, 이 길항방선균들로부터 단일성분으로 분리 정제된 여러 항생물질의 약효를 스크리닝한 결과, 그 항생물질중의 하나가 식물병원진균에 대해 뛰어난 항균활성 효과가 있음을 확인하고, 상기 항생물질에 대한 분자구조를 규명한 결과, 스타우로스포린을 확인하여 본 발명을 완성하게 된 것이다.Specifically, the present inventors have been conducting research to develop antifungal antibiotics from soil microorganisms since 1990 at the Department of Agricultural Biology, Korea University. Many antagonists generate antifungal antibiotics showing excellent antimicrobial activity against phytopathogenic fungi. Actinomycetes were discovered, and the screening effects of several antibiotics separated and purified from the antagonistic actinomycetes as a single component confirmed that one of the antibiotics had an excellent antimicrobial activity against phytopathogenic fungi. As a result of identifying the molecular structure of the antibiotic, the present invention was completed by identifying staurosporin.
즉, 본 발명자들은 한국의 여러 갯벌지역의 토양시료로부터 약 1,000여 개의 방선균을 분리하여 한천배지 및 온실조건하의 식물에서 병방제 효과를 검정한 결과, 역병균에 대하여 항균효과가 뛰어난 신규 방선균 균주 LS-A24 균주를 선발하여 스트렙토마이세스 로제오플라브스(Streptomyces roseoflavus)의 일종으로 동정하고 스트렙토마이세스 로제오플라브스 LS-A24(Streptomyces roseoflavus LS-A24)라 명명한 후 기탁[미생물기탁번호: KCCM 10505]함으로써 본 발명을 완성하게 되었으며, 이후 계속적인 연구를 통해 그로부터 생성되는 항균활성물질 스타우로스포린(staurosporine)을 분리, 정제하고, 그 구조를 결정함과 아울러 뛰어난 항진균효과를 발견하였는데, 이를 구체적으로 설명하면 다음과 같다.That is, the present inventors separated about 1,000 actinomycetes from soil samples of various tidal flat areas in Korea, and tested the control effect on plants under agar medium and greenhouse conditions. Details -A24 strains to identify a kind of Streptomyces ROGER O 'Rab's (Streptomyces roseoflavus) and Streptomyces ROGER O'Rab's LS-A24 (Streptomyces roseoflavus LS- A24) termed deposited after [microorganism accession number: KCCM 10505], the present invention was completed, and subsequent studies were performed to isolate and purify the antimicrobial agent staurosporine produced therefrom, to determine its structure, and to find an excellent antifungal effect. Explained as follows.
길항방선균을 선발하기 위하여 성환 지역의 호수토양에서 표토로부터 10㎝ 깊이의 토양을 채취하여 시료토양 5g씩을 50㎖의 멸균수에 혼합하고, 회전진탕기(150rpm)에서 30분간 진탕하여 토양현탁액을 제조하였다. 제조된 현탁액을 와트만 제1여과지(Watman No. 1 filter paper)를 통과시켜 여과하고, 멸균수로 1:100(v:v) 비율로 희석하였다. 각각의 희석액 1㎖를 40℃에서 녹은 휴믹애시드 비타민 한천배지(humic acid vitamin agar: 1.0g humic acid, 0.5g Na2HPO4, 1.71g KCl, 0.05g MgSO4ㆍH2O, 0.01g FeSO4ㆍH2O, 0.02g CaCO3 , 0.5mg thiamine-HCl, 0.5mg riboflavin, 0.5mg niacin, 0.5mg pyridoxin-HCl, 0.5mg inositol, 0.5mg Ca-pantothenate, 0.5mg p-aminobenzoic acid, 0.25mg biotin, 50mg cycloheximide, 18g agar, 1 liter H2O, adjusted to pH 7.2; vitamins and cycloheximide were filter-sterilized)와 0.85% NaCl이 첨가된 말트 추출물 한천배지(malt extract agar: 3g malt extract, 0.5g peptone, 0.5g glucose, 0.85% NaCl, 18g agar, 1 liter H2O)에 접종하고, 접종된 한천평판배지를 28℃에서 14일간 균총(colony)이 발생될 때까지 배양시켰다.In order to select antagonistic actinomycetes, soil 10cm deep from the topsoil was collected from the lake soil in the Sunghwan area, 5g of each sample soil was mixed with 50ml of sterile water, and shaken for 30 minutes in a rotary shaker (150rpm) to prepare a soil suspension. It was. The prepared suspension was filtered through Whatman 1 filter paper and diluted with sterile water in a 1: 100 (v: v) ratio. 1 ml of each diluent was dissolved at 40 ° C. Humic acid vitamin agar: 1.0 g humic acid, 0.5 g Na 2 HPO 4 , 1.71 g KCl, 0.05 g MgSO 4 ㆍ H 2 O, 0.01 g FeSO 4 H 2 O, 0.02 g CaCO 3 , 0.5 mg thiamine-HCl, 0.5 mg riboflavin, 0.5 mg niacin, 0.5 mg pyridoxin-HCl, 0.5 mg inositol, 0.5 mg Ca-pantothenate, 0.5 mg p-aminobenzoic acid, 0.25 mg biotin , 50mg cycloheximide, 18g agar, 1 liter H 2 O, adjusted to pH 7.2; vitamins and cycloheximide were filter-sterilized and malt extract agar: 3g malt extract, 0.5g peptone, 0.5 g glucose, 0.85% NaCl, 18 g agar, 1 liter H 2 O), and inoculated agar plate medium was incubated at 28 ℃ for 14 days until colonies were generated.
이렇게 하여 발생한 균총들 가운데 방선균으로 보이는 균총 즉, 일반 세균과는 달리 기질균사를 형성하여 한천배지 상에서 딱딱한 균총을 형성한 균총을 선택하여 고추역병균, 잿빛곰팡이병균, 사과탄저병균, 벼잎집무늬마름병균 및 벼도열병균에 대한 항균활성을 시험하였다.Among the germs generated in this way, the bacterium that appears to be actinomycetes, that is, unlike ordinary bacteria, selects a bacterium that forms a physiological mycelia and forms a hard mycelium on agar plate. The antimicrobial activity against bacteria and rice fever was tested.
이를 위하여, 선발된 방선균류를 브이팔 쥬스 한천배지(V8 juice agar, V8A)의 평판 가운데에서 30㎜ 떨어진 곳에 획선도말(streaking)하고 27℃에서 36시간 동안 배양한 후, 그 배지의 중앙에 증식중인 고추역병균 등 식물병원진균의 배양체로부터 떼어낸 균사절편(mycelial disk, 직경 7㎜)을 놓고 다시 5일간 배양한 뒤 저지원의 생성을 확인하였다.To this end, the selected actinomycetes are streaked at 30 mm away from the plate of V8 juice agar (V8A) and incubated for 36 hours at 27 ° C. Mycelial disks (mycelial disk, 7 mm in diameter) were removed from the cultures of phytopathogenic fungi, such as the causative fungal bacterium, incubated for another 5 days and confirmed the formation of low support.
저지원의 생성이 확인됨으로써 선발된 길항방선균은 순수배양물을 0.3% TSB배지에서 증식시킨 후에 15%의 글리세롤과 혼합하여 -70℃에서 보관하였으며, 일일사용을 위해서는 뚜껑이 달린 유리시험관(10×28㎜)에 담긴 0.3% TSA배지에 접종하여 사용하였다.The antagonistic bacteria selected by the production of low support were grown at 0.3% TSB medium, mixed with 15% glycerol, and stored at -70 ° C. Glass test tubes with lids for daily use (10 ×) 28 mm) was used to inoculate 0.3% TSA medium.
이렇게 분리, 선발된 균주를 스트렙토마이세스 로제오플라브스(Streptomyces roseoflavus)로 동정하여 스트렙토마이세스 로제오플라브스 LS-A24(Streptomyces roseoflavus LS-A24)라 명명하고, 하기와 같은 시험을 통해 항균활성을 가지는 2차대사산물을 정제하였다.This separation, to identify the selected strain as Streptomyces ROGER O 'Rab's (Streptomyces roseoflavus) Streptomyces ROGER O'Rab's LS-A24 (Streptomyces roseoflavus LS- A24) termed, and antimicrobial activity over the test as described below The secondary metabolite having was purified.
스트렙토마이세스 로제오플라브스 LS-A24 균주를 글리세롤 펩톤 배지 (glycerol peptone broth), 28℃에서 12일간 대량배양한 후 HP-20 resin으로 flash chromatography를 수행하였다. 각 fraction 중 항균활성 효과를 가진 MeOH 40%, 60%와 80%의 fraction을 합쳐, 에틸아세테이트(ethyl acetate)로 추출하여 이 유기용매 층에서 항균력을 보여 이 분획층을 수거하였다. 이 층을 농축하여 다시 C18 resin flash chromatography를 수행하였다. 60% 와 80% MeOH fraction을 모아서 thin layer chromatography를 수행, chloroform:methanol 9:1로 전개하여 항균력을 보이는 Rf 0.37 band를 MeOH로 수거하고, 이를 다시 Sephadex LH-20 column chromatography로 정제하여 항균활성 fraction 61-157번을 얻고, 이 항균활성 분획을 C18 reverse phase HPLC (eluent : 30%-1000% acetonitrile linear gradient system)를 2ml/min 속도로 수행하여 순화, 27.37분에서 항균활성 2차대사산물을 수득하고 스타우로스포린으로 동정하였다.Streptomyces roseoflaves LS-A24 strain was cultured in glycerol peptone broth, 28 ° C. for 12 days, and then subjected to flash chromatography with HP-20 resin. The fractions of 40%, 60% and 80% of MeOH with antimicrobial activity were combined and extracted with ethyl acetate to show antimicrobial activity in this organic solvent layer. The layer was concentrated and again subjected to C 18 resin flash chromatography. Collect 60% and 80% MeOH fraction and perform thin layer chromatography, develop chloroform: methanol 9: 1 to collect Rf 0.37 band showing antimicrobial activity with MeOH, and then refine it with Sephadex LH-20 column chromatography 61-157 were obtained and the antimicrobial activity fraction was purified by C 18 reverse phase HPLC (eluent: 30% -1000% acetonitrile linear gradient system) at a rate of 2ml / min. Obtained and identified as staurosporin.
이러한 방법으로 본 발명의 방선균주 스트렙토마이세스 로제오플라브스 LS-A24 균주로부터 분리 및 정제된 스타우로스포린은 하기와 같은 분자구조를 가진다.In this manner, the staurosporin isolated and purified from the actinomycetes Streptomyces roseoflavus LS-A24 strain of the present invention has the following molecular structure.
현재까지 알려져 있는 바로, 스타우로스포린은 1977년 S. Omura 등에 의해서 처음 Streptomyces로부터 분리된 microbial alkaroid계 화합물로서, antimicrobial activity 과 hypotensive activity가 발견된 이후, protein kinase C inhibitor로 많이 연구되어 알려져 있으며, protein kinase inhibitor가 항암효과를 가진다는 연구 이후로 그 약리 작용을 이용한 의학용으로 많은 관심을 받았으나, 식물병 항진균 활성에 대해서는 별로 알려진 바가 없는 물질이다.As known to date, staurosporin is a microbial alkaroid-based compound originally isolated from Streptomyces by S. Omura et al. In 1977. After antimicrobial and hypotensive activity was discovered, it has been known as a protein kinase C inhibitor. Since research on kinase inhibitors have anticancer effects, it has received much attention for medical use using its pharmacological effects, but little is known about phytopathogenic antifungal activity.
이상과 같이 본 발명의 방선균주 스트렙토마이세스 로제오스포린 LS-A24 균주로부터 분리, 정제된 항생물질 스타우로스포린은 기존의 유기합성 살균제인 대조군과 비교하여 동등한 수준의 방제효과가 있음이 확인되었는데, 특히, in vitro 상에서 고추 역병균(Phytophthora capsici)은 물론, 벼도열병(Magnaporthe grisea)과 라이족토니아 솔라니 (Rhizoctonia solani), 오이잿빛곰팡이병(Botrytis cinerea) 등에 대해서도 특이적인 항균활성을 나타냄으로써, 향후 식물병 방제에 이용성이 높을 것으로 기대되었다.As described above, it was confirmed that the antibiotic staurosporin isolated and purified from the actinomycetes Streptomyces roseosporin LS-A24 strain of the present invention had the same level of control effect as compared to the conventional organic synthetic fungicide. In particular, by showing the specific antimicrobial activity in vitro , as well as Phytophthora capsici , Magnaporthe grisea , Rhizoctonia solani, Cucumber rot fungus ( Botrytis cinerea ), etc. It is expected to be useful for controlling plant diseases in the future.
이하 실시예를 이용하여 상기와 같이 구성된 본 발명에 대해 보다 구체적으로 설명하고자 한다. 이들 실시예는 본 발명을 설명하기 위한 것으로, 본 발명의 범위가 이들 실시예에 국한되지 않는다는 것은 당 업계에서 통상의 지식을 가진 자에게 있어서 자명한 것이다.Hereinafter, the present invention configured as described above will be described in more detail with reference to the following examples. These examples are intended to illustrate the present invention, and it is obvious to those skilled in the art that the scope of the present invention is not limited to these examples.
[실시예 1] 길항방선균 LS-A24의 생리, 생화학적 특성 및 16S rDNA 서열 분석을 이용한 방선균 종 동정Example 1 Identification of Actinomycetes Species Using Physiological, Biochemical Properties and 16S rDNA Sequence Analysis of Antagonistic Actinomycetes LS-A24
성환 호수 토양에서 분리한 본 발명의 균주 LS-A24는 배지상에서 기질 균사를 생성하고, 세포벽의 다이아미노피멜릭애시드(diaminopimelic acid, DAP)가 L-form이고, 전자 현미경으로 포자 모양을 관찰한 결과 spiral형이며, 포자 표면이 매끈한 것을 보아 스트렙토마이세스 속임을 확인하였다(도 1). 종 동정을 위한 생리, 생화학적 시험은 매뉴얼 시스테메틱 박테리올로지(Bergey's manual of systematic bacteriology)에 서술되어 있는 방법으로 시행하였다. The strain LS-A24 of the present invention isolated from Sunghwan Lake soil produced substrate hyphae on the medium, diaminopimelic acid (DAP) on the cell wall was L-form, and the spores were observed by electron microscopy. Spiral, spore surface was found to be smooth to see Streptomyces cheat (Fig. 1). Physiological and biochemical tests for species identification were carried out using the methods described in the Manual's manual of systematic bacteriology.
상기 스트렙토마이세스 균주 LS-A24는 ISP 6, ISP 7배지에서 멜라닌 색소를 형성하지 않았으며, 엘라스틴(Elastin), 알부틴(Arbutin), 전분(Starch), 티로신(Tyrosine), 에스큐린(Esculin)을 분해하였으나, 잔틴(Xanthine), 카세인(Casein), 젤라틴(Gelatin)을 분해하지는 않았다. 이 균주는 자일로즈(Xylose), L-아바리노즈(Arabinose)를 탄소원으로 이용할 수 있었으나, 슈크로즈(Sucrose), 이노시톨(Inositol), 만니톨(Mannitol), 라피노즈(Raffinose), 람노즈(Rhamnose), 멜레지토즈(Melezitose), 자일리톨(Xylitol), 플루토즈(Fructose)는 이용할 수 없었다. 질소원으로 L-발린(Valine), L-히스티딘(Histidine)를 사용하였으나, L-시스테인(Cystein), L-페닐알라닌(Phenylalanine), L-하이드로자일프롤린(Hydroxyproline)은 이용할 수 없었다.The streptomyces strain LS-A24 did not form melanin pigment in ISP 6, ISP 7 medium, elastin (Elastin), arbutin (Arbutin), starch (Starch), Tyrosine (Tyrosine), Escurin (Esculin) However, Xanthine, Casein and Gelatin were not degraded. Xylose and L-Arabinose could be used as the carbon source, but the strain was sucrose, inositol, mannitol, raffinose, and ramnose. ), Melezitose, Xylitol, and Fructose were not available. L-valine and L-histidine were used as nitrogen sources, but L-cysteine, L-phenylalanine and L-hydroxylproline were not available.
상기 균주의 genomic DNA를 Pospiech와 Neumann의 방법에 따라 추출한 다음, 프라이머 fD1 (AGAGT TTGAT CCTGG CTCAG) 및 rP2 (ACGGC TACCT TGTTA CGACTT)을 이용하여 16S rDNA를 증폭하여 그 염기 서열을 분석하였다.Genomic DNA of the strain was extracted according to Pospiech and Neumann's method, and then the base sequence was analyzed by amplifying 16S rDNA using primers fD1 (AGAGT TTGAT CCTGG CTCAG) and rP2 (ACGGC TACCT TGTTA CGACTT).
분석된 서열을 GenBank에서 다른 방성균들의 것과 비교하고, 다른 방선균들과 본 발명 스트렙토마이세스 속 균주 LS-A24의 16S rDNA를 DNAstar 프로그램 내에 클러스트럴 방법으로 계통도를 그려 도 2에 나타내었다.The analyzed sequences were compared with those of other staphylococci in GenBank, and the 16S rDNA of the streptomyces sp. LS-A24 of the present invention and other Streptomyces strains were plotted by the cluster method in the DNAstar program and shown in FIG. 2.
이상의 생리생화학적인 시험과 16S rDNA 염기 서열 분석을 통하여 본 발명의 방선균 균주는 스트렙토마이세스 로제오플라브스(Streptomyces roseoflavus)의 일종으로 동정되었으며, 스트렙토마이세스 로제오플라브스 LS-A24(Streptomyces roseoflavus LS-A24)라 명명되었다.Through the above physiological biochemical test and 16S rDNA sequencing, the actinomycetes strain of the present invention was identified as a type of Streptomyces roseoflavus , and Streptomyces roseoflavus LS-A24 ( Streptomyces roseoflavus LS) -A24).
[실시예 2] 길항 방선균 LS-A24의 배양 조건Example 2 Culture Conditions of Antagonistic Actinomycetes LS-A24
미생물이 분비하는 물질은 배양기의 종류와 배양온도, 산소 공급율 등의 배양 조건에 따라 크게 달라지므로, 본 발명의 길항 방선균 LS-A24 균주가 항생물질을 최적으로 생산할 수 있는 배지 종류와 배양 시간을 알아보기 위해, 하기 4가지 종류의 배지를 선정하여 시험하였다.Since the substances secreted by microorganisms vary greatly depending on the culture conditions such as the type of incubator, the culture temperature, and the oxygen supply rate, the medium and culture time for which the antagonistic actinomycetes LS-A24 strain of the present invention can optimally produce antibiotics are determined. For viewing, the following four types of media were selected and tested.
전분카세인 배지(SCB, starch casein broth: 20g soluble starch, 0.6g tryptone peptone, 4g K2HPO4, 4g KNO3, 4g NaCl, 1g MgSO4ㆍ7H 2O, 0.02g FeSO4ㆍ7H2O, 0.04g CaCO3 and 1L distilled water )Starch casein medium (SCB, starch casein broth: 20g soluble starch, 0.6g tryptone peptone, 4g K 2 HPO 4 , 4g KNO 3 , 4g NaCl, 1g MgSO 4 7H 2 O, 0.02g FeSO 4 7H 2 O, 0.04 g CaCO 3 and 1L distilled water)
전분글루코즈 배지(SGB, starch glucose broth: 20g soluble starch, 10g glucose, 5g yeast extract, 5g casamino acid and 1L distilled water )Starch glucose broth (SGB, starch glucose broth: 20g soluble starch, 10g glucose, 5g yeast extract, 5g casamino acid and 1L distilled water)
글라이세롤덱스트린 배지(GDB, glycerol dextrin broth: 20g glycerol, 20g dextrin, 10g soytone, 3g yeast extract, 2g (NH4)2SO4, 4g K2HPO 4 and 1L distilled water)Glycerol dextrin broth (GDB, glycerol dextrin broth: 20g glycerol, 20g dextrin, 10g soytone, 3g yeast extract, 2g (NH 4 ) 2 SO 4 , 4g K 2 HPO 4 and 1L distilled water)
글라이세롤펩톤 배지(GPB, glycerol peptone broth : 20g glycerol, 10g polypeptone, 5g beef extract and 1L distilled water)Glycerol peptone broth (GPB, 20g glycerol, 10g polypeptone, 5g beef extract and 1L distilled water)
2, 4, 6, 8, 10, 12, 14일간의 배양 후, 배양여액을 농축하여 페이퍼디스크 방법으로 식물병에 대한 항균력을 비교하여 그 결과를 도 3에 나타내었다.After incubation for 2, 4, 6, 8, 10, 12, 14 days, the culture filtrate was concentrated and compared to the antimicrobial activity against plant diseases by the paper disk method is shown in Figure 3 the results.
시험 결과, 본 발명의 길항방성균 LS-A24는 글라이세롤펩톤 배지(GPB)에서 12일을 배양하였을 경우, 시험에 사용된 고추역병균에 대한 억제 효과가 가장 컸다.As a result of the test, the antagonistic bacteria LS-A24 of the present invention had the greatest inhibitory effect against the causative bacterium used in the test when cultured for 12 days in glycerol peptone medium (GPB).
[실시예 3] 항생물질 스타우로스포린의 분리 및 정제Example 3 Isolation and Purification of the Antibiotic Staurosporin
실시예 1 및 2에서 동정되고 배양조건이 확립된 본 발명의 길항방선균 스트렙토마이세스 로제오플라브스 LS-A24 균주로부터 항균활성을 가지는 2차대사산물을 분리 및 정제하기 위하여, 가장 항균 물질을 많이 생성하는 글리세롤 펩톤 배지(glycerol peptone broth)를 사용, 28℃에서 12일간 대량배양한 후, HP-20 resin에서 메탄올/물 0:100, 20:80, 40:60, 60:40, 80:20, 100:0(V/V) 혼합용매를 eluent로 하여 flash chromatography를 수행하였다.In order to isolate and purify the secondary metabolite having antimicrobial activity from the antagonistic Streptomyces rosoplavs LS-A24 strain of the present invention identified in Examples 1 and 2 and established in culture conditions, After culturing for 12 days at 28 ° C. using glycerol peptone broth, the resulting glycerol peptone broth was added to methanol / water 0: 100, 20:80, 40:60, 60:40, 80:20 in HP-20 resin. , Flash chromatography was performed using a 100: 0 (V / V) mixed solvent as eluent.
수득된 fraction 중 항균활성 효과를 가진 MeOH 40%, 60% 및 80%의 fraction과 cell mass 층을 메탄올로 추출한 항균력을 가진 메탄올 층을 합쳐, 다시 에틸아세테이트(ethyl acetate)로 추출하여 항균활성을 확인하고 수거한 다음, 이를 농축하여 다시 메탄올/물 0:100, 20:80, 40:60, 60:40, 80:20, 100:0(V/V) 혼합용매를 eluent로 하여 C18 resin flash chromatography를 수행하였다.From the fractions obtained, the fraction of MeOH 40%, 60% and 80% with antimicrobial activity and methanol layer with antimicrobial activity extracted from methanol were combined and extracted with ethyl acetate to confirm the antimicrobial activity. Collected, concentrated and concentrated to C 18 resin flash with eluent of methanol / water 0: 100, 20:80, 40:60, 60:40, 80:20, 100: 0 (V / V) Chromatography was performed.
60% 와 80% MeOH fraction을 모아서 silica gel plate로 thin layer chromatography(TLC)를 수행, chloroform:methanol 9:1로 전개하여 항균력을 보이는 Rf 0.37 band를 MeOH로 수거하고, 이를 다시 Sephadex LH-20 column chromatography로 정제하여 항균활성 fraction 61-157번을 얻고, 이 항균활성 분획을 C18 reverse phase HPLC(eluent: 30%-1000% acetonitrile linear gradient system)를 2ml/min 속도로 수행하여 순화, 27.37분에서 항균물질을 수득하였다.Collect 60% and 80% MeOH fractions, perform thin layer chromatography (TLC) on silica gel plate, expand to chloroform: methanol 9: 1, collect Rf 0.37 bands with antimicrobial activity, collect MeOH, and use Sephadex LH-20 column again. Purification by chromatography gave the antimicrobial activity fraction 61-157, which was purified by C 18 reverse phase HPLC (eluent: 30% -1000% acetonitrile linear gradient system) at a rate of 2ml / min, at 27.37 min. Antibacterial material was obtained.
이를 FAB 질량 분석기(FAB mass spectrum)으로 분석한 결과, 분자량이 466이고 분자식은 C28H26N4O3 이었으며, nuclear magnetic resonance (NMR) 분석한 결과 스타우로스포린(staurosporine)으로 확인되었다.As a result of analysis by FAB mass spectrum (FAB mass spectrum), the molecular weight was 466, the molecular formula was C 28 H 26 N 4 O 3 , nuclear magnetic resonance (NMR) analysis was confirmed as staurosporine (staurosporine).
[실시예 4] 식물병원진균에 대한 억제시험Example 4 Inhibition Test for Plant Pathogenic Fungi
실시예 3에서 수득된 스타우로스포린의 항균활성을 측정하기 위하여 하기와 같은 식물병원진균 억제시험을 수행하였다.In order to measure the antibacterial activity of staurosporin obtained in Example 3, the following phytopathogenic fungi inhibition test was performed.
고추역병균인 파이토프소라 캡시사이(P. capsici)를 비롯하여 벼도열병균(M. grisea), 알터나리아 말리(Alternaria mali), 클라도스포리움 오비큘라리에(Colletotrichum orbiculare), 보트리티스 시네리아(Botrytis cinerea), 클라도스포리움 쿠쿠메리눔(Cladosporium cucumerinum), 실린드로카폰 디스트럭탄스(Cylindrocarphon destructans), 디디멜라 브리오니에(Didymella bryoniae), 푸자리움 옥시스포룸 f.sp. 라이코퍼시시(Fusarium oxysporum f.sp. lycopercisi), 마그나포르테 그라이시아(Mygnaporthe grisea) 및 라이족토니아 솔라니( Rhizoctonia solani) 등의 식물병원 진균들을 감자 덱스트로스 한천(potato dextrose agar) 배지에서 배양하였다. M. grisea , Alternaria mali , Colletotrichum orbiiculare, Botrytis, as well as P. capsici Botrytis cinerea , Cladosporium cucumerinum , Cylindrocarphon destructans , Didymella bryoniae , Fusium oxysporum f.sp. Lycopene Percy when cultured at (Fusarium oxysporum f.sp. lycopercisi), Magna Forte that rayisiah (Mygnaporthe grisea) and Rhizoctonia solani Potato dextrose deck of phytopathogenic fungi such as (Rhizoctonia solani) agar (potato dextrose agar) medium .
스타우로스포린을 마이크로 웰 플레이트(micro-well plate)에 1%의 감자한천 액제배지와 섞어 일련의 농도(0.1∼100㎍/㎖)로 담은 후, 각각의 진균포자 또는 유주자 현탁액을 105개 포자/㎖의 농도로 맞추어서 각각의 웰(well)에 넣었다.Staurosporin is mixed with 1% potato agar medium in a micro-well plate and placed in a series of concentrations (0.1 to 100 µg / ml), followed by 10 5 spores of each fungal spore or yeast suspension. Each well was placed at a concentration of / ml.
접종된 웰 플레이트를 28℃에서 2일내지 4일간 배양한 후, 곰팡이의 균사생장이 일어나지 않은 농도중 가장 낮은 농도를 최소억제농도(minimum inhibitory concentration)로 평가하였으며, 그 결과를 하기 표 1에 나타내었다.After incubating the inoculated well plate at 28 ° C. for 2 to 4 days, the lowest concentration among the fungi without mycelial growth was evaluated as the minimum inhibitory concentration, and the results are shown in Table 1 below. It was.
시험 결과 본 발명의 길항방선균 스트렙토마이세스 로제오플라브스 LS-A24 균주로부터 분리된 스타우로스포린은 고추역병균인 파이토프소라 캡시사이(P. capsici), 콜렉토트리큠 오비큘라리에(C. orbiculare), 클라도스포리움 쿠쿠메리눔(C. cucumerinum)와 라이족토니아 솔라니(R. solani)에 대해 높은 수준의 항균활성을 보였으며, 오이잿빛곰팡이병균인 보트리티스 시네리아(Botrytis cinerea)와 푸자리움 옥시스포름 f.sp. 라이코퍼시시(Fusarium oxysporum f.sp. lycopersici)를 비롯하여 디디멜라 브리오니에(Didymella bryoniae)에 대해서도 50 ㎍/㎖와 10 ㎍/㎖ 등의 낮은 농도에서 항균활성을 나타내었다. 그러나, 알터나리아 말리와 마그나포르테 그라이시아에 대해서는 항균활성을 나타내지 않았다.As a result of the test, the staurosporin isolated from the antagonistic Streptomyces rosoplavs LS-A24 strain of the present invention is P. capsici , P. capsici , and C. aureus orbiculare ), C. cucumerinum ( C. cucumerinum) and R. solani ( R. solani ) showed high levels of antimicrobial activity, and Botrytis , a cucumber fungus cinerea ) and fujium oxysporum f.sp. Lycopersici ( Fusarium oxysporum f.sp. lycopersici ) and Didymella bryoniae also showed antimicrobial activity at low concentrations such as 50 ㎍ / ㎖ and 10 ㎍ / ㎖. However, it did not show antimicrobial activity against Alternaria Mali and Magna Porte Gracia.
[실시예 5] 스타우로스포린과 살균제 메타락실의 고추역병 방제효과 비교Example 5 Comparison of the Control Effect of Staurosporin and the Fungicide Metalaccil Against Red Pepper Disease
온실조건의 고추 유묘에서 역병방제용 상용 살균제인 메타락실과 본 발명의 길항방선균 스트렙토마이세스 로제오플라브스 LS-A24 균주로부터 생산되는 스타우로스포린의 역병방제효과를 비교 조사하였다.The pesticide control effect of metalaccil, a commercial bactericide for the control of late blight, and staurosporin produced from the antagonistic Streptomyces rosoplavs LS-A24 strain of greenhouse pepper seedlings in greenhouse conditions was investigated.
스타우로스포린과 메타락실을 0(무처리)부터 1000㎍/ml까지 농도별로 처리하고 1일후 역병균을 접종한 다음, 각 처리구와 약제를 처리하지 않은 무처리구에서의 병피해도(disease severity)를 평가하였다.Staurosporin and metalaxyl were treated at concentrations from 0 (untreated) to 1000 ㎍ / ml and inoculated with late blight after 1 day, and then treated with severity in untreated and untreated treatments. Evaluated.
고추역병 방제효과를 평가하기 위한 병 피해 정도는 무처리의 고추유묘가 완전히 병들어 죽었을 때를 기준으로 처리한 고추유묘에서 나타난 병 피해 정도에 따라 하기와 같이 0∼5 단위로 평가하였는데, 가시적인 병의 증상이 전혀 보이지 않을 때는 0으로, 완전히 고추유묘가 병들어 죽었을 때는 5로 등급을 매기어 평가하고 그 결과를 도 5에 나타내었다.The degree of disease damage for evaluating the control effect of red pepper disease was evaluated in units of 0 to 5 according to the degree of disease damage in the red pepper seedlings treated based on when the untreated red pepper seedlings were fully diseased and died. When the symptoms of phosphorus disease was not seen at all, and when the pepper seedlings were completely diseased and died, the rating was evaluated as 5 and the results are shown in FIG. 5.
0: 발병하지 않음0: no onset
1: 약간 발병(slightly wilted)과 병반(necrotic lesion)이 나타나기 시작1: lightly wilted and necrotic lesions begin to appear
2: 식물전체의 30-50% 정도 발병2: 30-50% of all plants
3: 식물전체의 50-80% 정도 발병3: 50-80% of all plants occur
4: 식물전체의 80-90% 정도 발병4: 80-90% of all plants occur
5: 식물의 죽음5: plant death
시험 결과, 역병균 접종 후 2일째부터 약제를 처리하지 않은 고추식물의 줄기에서 갈색병반이 나타나기 시작한 반면, 메타락실과 스타우로스포린을 처리한 고추식물에서는 병징이 관찰되지 않았으며, 접종후 3일이 되면서 스타우로스포린 1㎍/ml와 10㎍/ml의 약제처리구의 고추식물에서도 병반이 관찰되기 시작하였고, 메타락실 10㎍/ml을 처리한 고추식물에서도 약간의 시들음 증상이 관찰되었다.As a result, brown plaques began to appear on the stems of untreated red pepper plants from day 2 after the inoculation of the bacterium, whereas no symptoms were observed in the red pepper plants treated with metalaccil and staurosporin. As a result, lesions began to be observed in pepper plants of 1 µg / ml and 10 µg / ml drug treatments, and some withering symptoms were also observed in pepper plants treated with metalaccil 10 µg / ml.
접종 5일 후, 메타락실 100㎍/ml 약제를 처리한 고추식물은 병증상이 보이지 않았으나, 항생물질 스타우로스포린은 500㎍/ml이 처리된 고추식물에서 병이 발생하지 않았다.After 5 days of inoculation, pepper plants treated with 100 mg / ml of metalaxyl did not show any symptoms, but antibiotic staurosporin did not develop in 500 µg / ml treated pepper plants.
스타우로스포린 처리구 500㎍/ml이상의 처리시에 역병이 발생하지 않아서, 항진균물질 스타우로스포린이 고추역병 방제 효과면에서, 도 5 에 도시된 바와 같이, 메타락실과 동등한 수준의 방제효과를 보였다고 할 수 있다. 이러한 시험 결과를 볼 때, 본 발명에 이용된 토양 방선균 유래 스타우로스포린이 유기합성 살균제 유효 성분과 거의 동일한 수준의 병방제 효과를 가지고 있음을 알 수 있다.Since no late blight did not occur in the treatment of more than 500µg / ml of staurosporin treatment, the antifungal substance staurosporin showed the same level of control effect as metalaccil as shown in FIG. Can be. From these test results, it can be seen that the soil actinomycetes-derived staurosporin used in the present invention had almost the same level of control effect as the active ingredient of the organic synthetic fungicide.
이상과 같이 항균활성을 가지는 본 발명의 스트렙토마이세스 로제오플라브스 LS-A24 균주가 분리, 동정되고, 그 2차대사산물인 스타우로스포린이 분리, 정제됨과 동시에 항균활성이 확인됨으로써, 스트렙토마이세스 로제오플라브스 LS-A24(Streptomyces roseoflavus LS-A24) 균주 또는 이 균주의 배양여액을 사용하는 식물병 방제용 살균제 및 정제된 스타우로스포린을 함유하는 식물병 방제용 살균제가 제공될 수 있게 되었다.As described above, the Streptomyces roseoflavus LS-A24 strain of the present invention having antimicrobial activity is isolated and identified, and the second metabolite, staurosporin, is isolated and purified and the antimicrobial activity is confirmed, thereby streptomycin Plant disease control fungicides using the Streptomyces roseoflavus LS-A24 strain or the culture filtrate of the strain and plant fungicides containing purified staurosporin can be provided. .
또한, 본 발명의 스트렙토마이세스 로제오플라브스 LS-A24(Streptomyces roseoflavus LS-A24) 균주, 이 균주의 배양여액, 및 이 균주로부터 정제된 항균물질 스타우로스포린은 모두 원래 천연 유래의 물질로서, 자연 환경 상에서 미생물에 의해 쉽게 분해될 수 있는 물질이므로, 단독 또는 본 발명이 속하는 기술분야에서 통상적으로 사용되는 충전제 등을 혼합하여 무공해, 친환경 살균제 조성물을 제조하는 데에 사용할 수 있게 되었다고 할 수 있다.In addition, the Streptomyces roseoflavus LS-A24 strain of the present invention, the culture filtrate of this strain, and the antibacterial substance staurosporin purified from the strain are all originally derived from nature, Since the material can be easily decomposed by the microorganisms in the natural environment, it can be said that it can be used to prepare a pollution-free, environmentally friendly fungicide composition alone or by mixing a filler or the like commonly used in the art.
이상과 같이 본 발명이 완성됨으로써, 토양으로부터 분리한 신규의 스트렙토마이세스 로제오플라브스 LS-A24(Streptomyces roseoflavus LS-A24) 균주와 이 균주 배양액으로부터 분리, 추출되는 항균물질인 스타우로스포린(staurosporine) 및 이 항생물질을 이용하는 식물병 방제용 살균제 등이 제공될 수 있게 되었다.By completing the present invention as described above, the novel Streptomyces roseoflavus LS-A24 strain isolated from the soil, and the staurosporine which is an antimicrobial substance separated and extracted from the strain culture medium. ) And fungicides for controlling plant diseases using the antibiotics can be provided.
본 발명이 완성됨으로써, 고추역병, 잿빛곰팡이병 등의 식물병 방제에 사용될 수 있는, 유기합성계 농약 수준의 높은 방제효과를 가지고 있으면서도 저독성이고 환경에 부작용을 일으키지 않는 친환경적 무공해 살균제가 제공될 수 있게 된 것이다.By the completion of the present invention, it is possible to provide an environmentally friendly pollution-free fungicide that has a high control effect of the organic synthetic pesticides level, which can be used for controlling plant diseases such as red pepper disease, gray mold disease, and the like, which is low toxicity and does not cause adverse effects on the environment. will be.
본 발명에 의하여 제공되는 살균제 조성물은 주요한 식물병원균, 예를 들어, 보트리티스 시네리아(Botrytis cinerea), 클라도스포리움 쿠쿠메리눔(Cladosporium cucumerinum), 디디멜라 브리오니에(Didymella bryoniae), 푸자리움 옥시스포름 f.sp. 라이코퍼시시(Fusarium oxysporum f.sp. lycopersici), 콜렉토트리큠 오비큘라리에(Collectotrichum orbiculare), 라이족토니아 솔라니 (Rhizoctonia solani), 파이토프소라 캡시사이(Phytophthora capsici) 등에 의한 식물병의 방제에 이용될 수 있다.Fungicide compositions provided by the present invention are major phytopathogens, such as Botrytis cinerea , Cladosporium cucumerinum , Didymella bryoniae , Fuzarium Oxysporum f.sp. Percy lycopene during the (Fusarium oxysporum f.sp. Lycopersici), call tree rekto kyum plant disease caused by a Ob particulate lari (Collectotrichum orbiculare), Rhizoctonia solani (Rhizoctonia solani), between the pie Saratov seashell kaepsi (Phytophthora capsici) It can be used for control.
도 1은 스트렙토마이세스 로제오플라브스 LS-A24 균주의 주사전자현미경 사진이고,1 is a scanning electron micrograph of the Streptomyces roseoflavus LS-A24 strain,
도 2는 스트렙토마이세스 30여 종의 16S rDNA 염기 서열을 바탕으로 한 계통도이고,Figure 2 is a phylogenetic tree based on the streptomyces 30 species of 16S rDNA nucleotide sequence,
도 3은 배양 배지와 배양 시간에 따른 본 발명의 식물병원균에 대한 억제 효과를 보인 그래프이고,Figure 3 is a graph showing the inhibitory effect on the phytopathogens of the present invention according to the culture medium and incubation time,
도 4은 본 발명 스트렙토마이세스 로제오플라브스 LS-A24의 배양 여액에서 스타우로스포린의 정제 과정을 보인 공정도이고,Figure 4 is a process chart showing the purification process of staurosporin in the culture filtrate of Streptomyces roseoflavus LS-A24 of the present invention,
도 5는 온실조건의 폿트실험에서 본 발명 항생물질의 고추역병에 대한 방제효과를 상용살균제인 메타락실(metalaxyl)과 비교 시험한 그래프이다.5 is a graph comparing the control effect of the antibiotics of the present invention against pepper blight in pot experiments of greenhouse conditions compared with metalaxyl, a commercial fungicide.
Claims (6)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020040000735A KR20050072341A (en) | 2004-01-06 | 2004-01-06 | Streptomyces roseoflavus ls-a24 strain effective against plant pathogenic fungi and fungicides produced from it |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020040000735A KR20050072341A (en) | 2004-01-06 | 2004-01-06 | Streptomyces roseoflavus ls-a24 strain effective against plant pathogenic fungi and fungicides produced from it |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20050072341A true KR20050072341A (en) | 2005-07-11 |
Family
ID=37261818
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020040000735A Ceased KR20050072341A (en) | 2004-01-06 | 2004-01-06 | Streptomyces roseoflavus ls-a24 strain effective against plant pathogenic fungi and fungicides produced from it |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR20050072341A (en) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100790314B1 (en) * | 2006-11-10 | 2008-01-02 | 고려대학교 산학협력단 | Novel antibiotic salasein produced from Streptomyces racei Ms. 553 strain with antimicrobial activity and preparation method thereof |
| KR100977530B1 (en) * | 2008-04-01 | 2010-08-23 | 경북대학교 산학협력단 | Streptomyces sp. WD414 strain, plant disease control agent containing same, and plant disease control method using same |
| CN1928069B (en) * | 2005-09-08 | 2010-09-08 | 上海市农药研究所 | A kind of streptomyces actinomyces and its application |
| KR101101783B1 (en) * | 2010-02-08 | 2012-01-05 | 주식회사 해강바이오 | Novel Streptomyces spp. With excellent antimicrobial activity and insecticidal properties and its culture method and preparations using cultures |
| CN103004533A (en) * | 2012-11-27 | 2013-04-03 | 天津滨海国际花卉科技园区股份有限公司 | Method for preventing cyclamen wilt disease |
| WO2013100655A1 (en) * | 2011-12-27 | 2013-07-04 | 대한민국(농촌진흥청장) | Composition for controlling bacterial leaf blight of rice |
| CN106701631A (en) * | 2017-01-19 | 2017-05-24 | 中国农业科学院植物保护研究所 | Strain of streptomyces roseoflavus and application thereof |
| CN108402057A (en) * | 2018-03-07 | 2018-08-17 | 中国热带农业科学院热带生物技术研究所 | Application of the indole carbazole compound in preparing resisting banana vascular wilt cause of disease microbial inoculum |
| KR20230065690A (en) * | 2021-11-05 | 2023-05-12 | 전남대학교산학협력단 | Composition for controlling plant disease comprising culture solution of Streptomyces sp. JCK-6116 Strain or extract thereof, manufacturing methods thereof and controlling method for phytopathogenic fungi |
-
2004
- 2004-01-06 KR KR1020040000735A patent/KR20050072341A/en not_active Ceased
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1928069B (en) * | 2005-09-08 | 2010-09-08 | 上海市农药研究所 | A kind of streptomyces actinomyces and its application |
| KR100790314B1 (en) * | 2006-11-10 | 2008-01-02 | 고려대학교 산학협력단 | Novel antibiotic salasein produced from Streptomyces racei Ms. 553 strain with antimicrobial activity and preparation method thereof |
| KR100977530B1 (en) * | 2008-04-01 | 2010-08-23 | 경북대학교 산학협력단 | Streptomyces sp. WD414 strain, plant disease control agent containing same, and plant disease control method using same |
| KR101101783B1 (en) * | 2010-02-08 | 2012-01-05 | 주식회사 해강바이오 | Novel Streptomyces spp. With excellent antimicrobial activity and insecticidal properties and its culture method and preparations using cultures |
| WO2013100655A1 (en) * | 2011-12-27 | 2013-07-04 | 대한민국(농촌진흥청장) | Composition for controlling bacterial leaf blight of rice |
| KR101313783B1 (en) * | 2011-12-27 | 2013-10-02 | 명지대학교 산학협력단 | Composition for rice bacterial blight suppressing activity |
| CN103004533A (en) * | 2012-11-27 | 2013-04-03 | 天津滨海国际花卉科技园区股份有限公司 | Method for preventing cyclamen wilt disease |
| CN106701631A (en) * | 2017-01-19 | 2017-05-24 | 中国农业科学院植物保护研究所 | Strain of streptomyces roseoflavus and application thereof |
| CN106701631B (en) * | 2017-01-19 | 2020-06-05 | 中国农业科学院植物保护研究所 | A strain of Streptomyces roseus and its application |
| CN108402057A (en) * | 2018-03-07 | 2018-08-17 | 中国热带农业科学院热带生物技术研究所 | Application of the indole carbazole compound in preparing resisting banana vascular wilt cause of disease microbial inoculum |
| KR20230065690A (en) * | 2021-11-05 | 2023-05-12 | 전남대학교산학협력단 | Composition for controlling plant disease comprising culture solution of Streptomyces sp. JCK-6116 Strain or extract thereof, manufacturing methods thereof and controlling method for phytopathogenic fungi |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI251465B (en) | A novel strain of streptomyces for controlling plant diseases | |
| US5968503A (en) | Use of streptomyces bacteria to control plant pathogens and degrade turf thatch | |
| KR101291915B1 (en) | Bacillus amyloliquefaciens GYL4 effective against plant pathogenic fungi and method for preparing antibiotics using the same | |
| US10477865B2 (en) | Fungicidal compounds and methods of their use | |
| WO1996029874A1 (en) | Use of streptomyces bacteria to control plant pathogens and degrade turf thatch | |
| EP3520614B1 (en) | Use of grammicin as active ingredient in a nematode control method | |
| KR100665539B1 (en) | Plant activator and preparation method thereof, plant activator and use method thereof | |
| KR101423663B1 (en) | Streptomyces mauvecolor strain effective against plant pathogenic fungi and derivative rimocidin antibiotic produced therefrom | |
| JP3668008B2 (en) | New strains of Streptomyces and their use | |
| KR20050072341A (en) | Streptomyces roseoflavus ls-a24 strain effective against plant pathogenic fungi and fungicides produced from it | |
| KR101330381B1 (en) | Streptomyces hygroscopicus subsp. enhygrus strain effective against plant pathogenic fungi and method for preparing antibiotics using the same | |
| US20030130121A1 (en) | Novel bacterial isolate and the preparation and use of its active metabolites | |
| KR20230001353A (en) | Composition for controlling plant diseases comprising compound lsolated from Trichoderma longibrachiatum as an active ingredient and method of controlling plant diseases using the same | |
| KR20120028083A (en) | Streptomyces psammoticus strain effective against plant pathogens and method for preparing antibiotics using the same | |
| KR100477890B1 (en) | A new Streptomyces sp. 8E12 and its use as a herbicidal agent | |
| KR100612041B1 (en) | Novel Streptomyces catensis VK-A60 strain having antibacterial activity against phytopathogens and fungicides produced from the strain | |
| KR102654146B1 (en) | Composition for controlling plant fungus disease comprising culture solution of Bacillus velezensis CE 100 or extract thereof, manufacturing methods thereof and controlling method for plant fungus disease | |
| KR100604199B1 (en) | Novel Streptomyces catensis VK-A60 strain having antibacterial activity against phytopathogens and fungicides produced from the strain | |
| KR100876431B1 (en) | Streptomyces sp. MB121 strain, and a plant disease control agent containing the same | |
| KR100327510B1 (en) | Antifungal activity and Preparation-method of antibiotics produced from Micromonospora coerulea Ao58 | |
| KR100489914B1 (en) | Preparation method and antioomycete activity of a novel antibiotic produced by Lechevalieria aerocolonigenes strain VK-A9 against Phytophthora capsici | |
| KR20010038285A (en) | Pseudomonas aeruginosa B5 having antifungal activity and a Method of Preparation for antibiotics produced from the bacteria | |
| KR101381828B1 (en) | Composition for controlling plant pathogenic fungi comprising niphimycin | |
| KR20060012393A (en) | Novel Bacillus strains inhibit potato potato beetle disease, antibiotics produced by the strain and microbial preparations containing the same | |
| KR100790314B1 (en) | Novel antibiotic salasein produced from Streptomyces racei Ms. 553 strain with antimicrobial activity and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20040106 |
|
| PA0201 | Request for examination | ||
| PG1501 | Laying open of application | ||
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20051004 Patent event code: PE09021S01D |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 20060102 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20051004 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |